Chemoinformaics analysis of Methyl alpha-D-galactopyranoside
Molecular Weight | 194.183 | nRot | 2 |
Heavy Atom Molecular Weight | 180.071 | nRig | 6 |
Exact Molecular Weight | 194.079 | nRing | 1 |
Solubility: LogS | -0.07 | nHRing | 1 |
Solubility: LogP | -2.139 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 7 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
nHA | 6 | APOL | 25.8371 |
nHD | 4 | BPOL | 17.5169 |
QED | 0.386 |
Synth | 3.505 |
Natural Product Likeliness | 2.574 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.076 |
HIA | 0.876 |
CACO-2 | -5.262 |
MDCK | 0.000805272 |
BBB | 0.467 |
PPB | 0.122474 |
VDSS | 0.471 |
FU | 0.818249 |
CYP1A2-inh | 0.006 |
CYP1A2-sub | 0.075 |
CYP2c19-inh | 0.008 |
CYP2c19-sub | 0.439 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.087 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.142 |
CYP3a4-inh | 0.004 |
CYP3a4-sub | 0.021 |
CL | 1.614 |
T12 | 0.61 |
hERG | 0.028 |
Ames | 0.344 |
ROA | 0.136 |
SkinSen | 0.046 |
Carcinogencity | 0.024 |
EI | 0.036 |
Respiratory | 0.023 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.889347 |